RhumbLine Advisers’s Entrada Therapeutics TRDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $263K | Buy |
39,095
+2,982
| +8% | +$20K | ﹤0.01% | 3078 |
|
|
2025
Q1 | $326K | Sell |
36,113
-618
| -2% | -$5.59K | ﹤0.01% | 2840 |
|
|
2024
Q4 | $635K | Buy |
36,731
+433
| +1% | +$7.49K | ﹤0.01% | 2517 |
|
|
2024
Q3 | $580K | Sell |
36,298
-642
| -2% | -$10.3K | ﹤0.01% | 2601 |
|
|
2024
Q2 | $526K | Buy |
36,940
+7,452
| +25% | +$106K | ﹤0.01% | 2646 |
|
|
2024
Q1 | $418K | Buy |
29,488
+996
| +3% | +$14.1K | ﹤0.01% | 2778 |
|
|
2023
Q4 | $430K | Buy |
28,492
+2,043
| +8% | +$30.8K | ﹤0.01% | 2755 |
|
|
2023
Q3 | $418K | Buy |
26,449
+2,230
| +9% | +$35.2K | ﹤0.01% | 2717 |
|
|
2023
Q2 | $367K | Buy |
+24,219
| New | +$367K | ﹤0.01% | 2885 |
|